Endoscopic Ultrasound–Guided Celiac Plexus Neurolysis for Pain Management in Patients with Pancreatic Carcinoma Reasons to Fight a Losing Battle

Xiaoping Zou,Su-Yu Chen,Ying Lv,Wen Li,Xiaoqi Zhang

DOI: https://doi.org/10.1097/mpa.0b013e31823d06a9

2012-01-01

Pancreas

Abstract:Zou, Xiao-Ping MD; Chen, Su-Yu MD; Lv, Ying MD; Li, Wen MM; Zhang, Xiao-Qi MD Author Information

What problem does this paper attempt to address?

EUS-CGN Versus EUS-CPN in Pancreatic Cancer

Mao Li,Zihe Wang,Yang Chen,Zuowei Wu,Xing Huang,Chao Wu,Bole Tian

DOI: https://doi.org/10.1097/md.0000000000027103

IF: 1.6

2021-01-01

Medicine

Abstract:Comparison between endosonographic ultrasonography (EUS)-guided celiac ganglia neurolysis (CGN) and EUS-guided celiac plexus neurolysis (CPN) in pain management for pancreatic cancer has engendered controversy. To analyze the effectiveness and safety of EUS-CGN and figure out whether EUS-CGN is better than EUS-CPN, a qualitative systematic review was conducted.Studies were searched from Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE up to April 2020. We only included studies with full-text and in English and assessed study quality with Newcastle-Ottawa Scale or Cochrane risk-of-bias tool. We recorded details of study design, participants, procedure performed, protocol of follow-up, pain response, quality of life, survival, and adverse events. The study was conducted under Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement 2009.Five studies involving 319 patients were included. Short-term pain response rates ranged from 65.0% to 88.46% in EUS-CGN group and most studies reported its superiority over EUS-CPN. As for adverse events, the incidence of transient hypotension and gastrointestinal symptoms seemed comparable, while results of initial pain exacerbation varied among studies. Besides, EUS-CGN might provide a shorter survival.EUS-CGN can be safely performed while it may shorten survival. In terms of short-term pain response, EUS-CGN is better than EUS-CPN while no conclusion of long-term pain control can be drawn.
A Prospective Study of Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis for Pain Management in Patients with Pancreatic Carcinoma

ZOU Xiao-ping,CHEN Su-yu,L(U) Ying,ZHANG Xiao-qi,LI Wen,XU Zhao-min

DOI: https://doi.org/10.3760/cma.j.issn.1007-5232.2011.11.008

2011-01-01

Abstract:Objective To prospectively assess the efficacy and safety of endoscopic ultrasoundguided celiac plexus neurolysis (EUS-CPN) in the management of pain caused by pancreatic carcinoma.Methods Patients with confirmed un-resectable pancreatic malignancy were treated with EUS-CPN once or twice.The data including age,gender,pain duration,opioid consumption,tumor location,pain scores before and after the procedure,number of treatment,duration of pain relief and survival time were collected.Results A total of 27 cases with cancerous abdominal pain were recruited.The median pain scores were significantly lower after EUS-CPN,and pain relief was obtained in 81.5％ (95％ CI,66.8％ -96.1％ ) patients with a median duration of 56.0 days (95％ CI,17.1-94.9),whose confidence interval was comparable to that of survival time (97.0 days,95 ％ CI,82.7-111.3 ).No clinical factors could predict post-procedure duration of pain relief (x2 =6.757,P =0.239).Procedure-related transient diarrhea and fever were noted only in 1 patient.No major complications occurred.Conclusion EUS-guided CPN is safe and effective in alleviating abdominal pain associated with pancreatic cancer,even at the late stage.Moreover,no clinical factor could predict post-procedure degree or duration of pain relief.
How to Improve the Efficacy of Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis in Pain Management in Patients with Pancreatic Cancer: Analysis in A Single Center

Hao Si-Jie,Xu Wei-Jia,Di Yang,Yao Lie,Yang Feng,Jiang Yong-Jian,Li Ji,Jin Chen,Zhong Liang,Fu De-Liang

DOI: https://doi.org/10.1097/sle.0000000000000032

2014-01-01

Surgical Laparoscopy Endoscopy & Percutaneous Techniques

Abstract:Visceral pain secondary to pancreatic cancer is often difficult to control and poses a challenge to the physician. We retrospectively analyzed the efficacy and safety of endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) in patients with unresectable pancreatic cancer. Forty-one patients with severe pain despite treatment with opioids underwent EUS-CPN with absolute alcohol. Patients scored their pain on a scale of 0 to 10 and were interviewed after the procedure. Of the 41 patients, 33, 37, and 25 patients reported improvement in their pain within 3 days, at 1 week, and at 3 months, respectively, following the procedure. Of all the patients, 19 patients reported substantial improvement and 4 patients showed complete disappearance of pain. Complication appeared in 2 patients with transient hypotension. In our study, EUS-CPN is a safe and effective form of treatment for intractable pain secondary to advanced pancreatic cancer.
Therapeutic role of endoscopic ultrasound in pancreaticobiliary disease: A comprehensive review.

Fan-Sheng Meng,Zhao-Hong Zhang,Feng Ji

DOI: https://doi.org/10.3748/wjg.v21.i46.12996

IF: 5.374

2015-01-01

World Journal of Gastroenterology

Abstract:With the development of technology and accessories, the role of endoscopic ultrasound (EUS) has evolved from diagnostics to therapeutics. In order to characterise the therapeutic role of EUS, we searched Web of Knowledge database and reviewed articles associated with therapeutic EUS. There are two modalities for the therapeutic purpose: drainage and fine-needle injection. EUS-guided drainage is a promising procedure for the treatment of peripancreatic fluid collection and biliary obstruction; EUS-guided fine-needle injections such as celiac plexus neurolysis, for the purpose of pain relief for pancreatic cancer and chronic pancreatitis, has emerged as a promising procedure. The aim of the study was to perform a comprehensive and conscientious review on the techniques, complications and clinical outcomes of those EUS-based procedures.
Management of Primary Squamous Cell Carcinoma of the Pancreas: A Case Report.

Danling Guo,Chao Chen,Sangying Lv,Guanzuan Wu,Wei Shi,Huaifeng Li,Hongjie Hu

DOI: https://doi.org/10.3389/fsurg.2021.700229

IF: 1.8

2021-01-01

Frontiers in Surgery

Abstract:Introduction: Primary squamous cell carcinoma of the pancreas (SCCP) is a rare malignant tumor that has been reported in individual case reports only. The clinical data on primary SCCP treatment are limited. Therefore, the appropriate management strategy for this disease should be standardized. Case Presentation: We present the case of a 63-year-old man admitted to our hospital for upper left abdominal pain for 2 months without weight loss or jaundice. Enhanced computed tomography (CT) and magnetic resonance imaging (MRI) of the abdomen revealed a mixed solid and cystic lesion in the pancreatic tail, measuring 35 × 37 mm in maximum diameter with enhancement. The patient was diagnosed with primary SCCP without metastasis, based on radiological and pathological findings. He did not receive neoadjuvant therapy postoperatively and was followed up by CT and MRI for 18 months without recurrence or metastasis. Result: Complete resection is the most effective treatment for early stage primary SCCP. Abdominal MRI is an effective imaging tool for preoperative evaluation and postoperative follow-up of primary SCCP. The need for neoadjuvant therapy depends on various factors. Conclusion: Primary SCCP is a tumor with poor prognosis. Risk factor control, early accurate radiologic evaluation, and individualized treatment strategies improve the quality of life and prolong the overall survival period of patients.
Which is the Best Surgical Approach for the Pancreatic Cancer? A Classification of Pancreatic Cancer to Guide Operative Decisions is Needed

Min Wang,Feng Zhu,Renyi Qin,Shu-you Peng

DOI: https://doi.org/10.1097/sla.0000000000001271

IF: 13.787

2017-01-01

Annals of Surgery

Abstract:Wang, Min MD; Zhu, Feng MD; Qin, Renyi MD, FACS; Peng, Shuyou MD, FACS(Hon), FRCSGlasg Author Information
Endoscopic ultrasound-guided neurolysis in advanced pancreatic cancer: current status

Katy Hickman,Edmund Godfrey,Thankamma Ajithkumar

DOI: https://doi.org/10.1136/bmjspcare-2021-002905

2021-10-11

Abstract:Pancreatic cancer has a very poor prognosis with patients often presenting with locally advanced, inoperable or metastatic disease. A significant proportion of patients have visceral pain due to perineural infiltration or coeliac plexus involvement by the tumour. This pain is difficult to control and may become refractory to conventional pain management. Therefore, coeliac plexus neurolysis (CPN) has been proposed to ablate the neuronal transmission pathway of pain permanently. CPN is recommended for those who have uncontrolled pain, are experiencing unacceptable opioid adverse effects or are receiving escalating doses of analgesics. It is not known whether CPN performed at diagnosis as the first-line treatment (‘early’) would impact short-term and long-term pain control and quality of life. NICE has recommended (2018) a randomised trial comparing early endoscopic ultrasound-guided coeliac plexus neurolysis (EUS-CPN) with on-demand EUS-CPN in pancreatic cancer. In this context, we will review the current evidence on its clinical benefits.

health care sciences & services
Practice guidelines for endoscopic ultrasound-guided celiac plexus neurolysis

Jonathan M. Wyse,Robert Battat,Siyu Sun,Adrian Saftoiu,Ali A. Siddiqui,Ang Tiing Leong,Brenda Lucia Arturo Arias,Carlo Fabbri,Douglas G. Adler,Erwin Santo,Evangelos Kalaitzakis,Everson Artifon,Girish Mishra,Hussein Hassan Okasha,Jan Werner Poley,Jintao Guo,Juan J. Vila,Linda S. Lee,Malay Sharma,Manoop S. Bhutani,Marc Giovannini,Masayuki Kitano,Mohamad Ali Eloubeidi,Mouen A. Khashab,Nam Q. Nguyen,Payal Saxena,Peter Vilmann,Pietro Fusaroli,Pramod Kumar Garg,Sammy Ho,Shuntaro Mukai,Silvia Carrara,Subbaramiah Sridhar,Sundeep Lakhtakia,Surinder S. Rana,Vinay Dhir,Anand V. Sahai,AnandV Sahai,JonathanM Wyse,AliA Siddiqui,AngTiing Leong,BrendaLucia Arturo Arias,DouglasG Adler,HusseinHassan Okasha,JanWerner Poley,JuanJ Vila,LindaS Lee,ManoopS Bhutani,MohamadAli Eloubeidi,MouenA Khashab,NamQ Nguyen,PramodKumar Garg,SurinderS Rana

DOI: https://doi.org/10.4103/eus.eus_97_17

2017-01-01

Endoscopic Ultrasound

Abstract:OBJECTIVES: The objective of guideline was to provide clear and relevant consensus statements to form a practical guideline for clinicians on the indications, optimal technique, safety and efficacy of endoscopic ultrasound guided celiac plexus neurolysis (EUS-CPN).METHODS: Six important clinical questions were determined regarding EUS-CPN. Following a detailed literature review, 6 statements were proposed attempting to answer those questions. A group of expert endosonographers convened in Chicago, United States (May 2016), where the statements were presented and feedback provided. Subsequently a consensus group of 35 expert endosonographers voted based on their individual level of agreement. A strong recommendation required 80% voter agreement. The modified GRADE (Grading of Recommendations Assessment, Development, and Evaluation) criteria were used to rate the strength of recommendations and the quality of evidence.RESULTS: Eighty percent agreement was reached on 5 of 6 consensus statements, 79.4% agreement was reached on the remaining one.CONCLUSIONS: EUS-CPN is efficacious, should be integrated into the management of pancreas cancer pain, and can be considered early at the time of diagnosis of inoperable disease. Techniques may still vary based on operator experience. Serious complications exist, but are rare.

gastroenterology & hepatology
Predictors of pain response after endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain caused by pancreatic malignancy

Chao-Qun Han,Xue-Lian Tang,Qin Zhang,Chi Nie,Jun Liu,Zhen Ding

DOI: https://doi.org/10.3748/wjg.v27.i1.69

IF: 5.374

2021-01-07

World Journal of Gastroenterology

Abstract:Endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) has gained popularity as a minimally invasive approach and is currently widely used to treat pancreatic cancer-associated pain. However, response to treatment is variable.To identify the efficacy of EUS-CPN and explore determinants of pain response in EUS-CPN for pancreatic cancer-associated pain.A retrospective study of 58 patients with abdominal pain due to inoperable pancreatic cancer who underwent EUS-CPN were included. The efficacy for palliation of pain was evaluated based on the visual analog scale pain score at 1 wk and 4 wk after EUS-CPN. Univariable and multivariable logistic regression analyses were performed to explore predictors of pain response.A good pain response was obtained in 74.1% and 67.2% of patients at 1 wk and 4 wk, respectively. Tumors located in the body/tail of the pancreas and patients receiving bilateral treatment were weakly associated with a good outcome. Multivariate analysis revealed patients with invisible ganglia and metastatic disease were significant factors for a negative response to EUS-CPN at 1 wk and 4 wk, respectively, particularly for invasion of the celiac plexus (odds ratio (OR) = 13.20, = 0.003 for 1 wk and OR = 15.11, = 0.001 for 4 wk). No severe adverse events were reported.EUS-CPN is a safe and effective form of treatment for intractable pancreatic cancer-associated pain. Invisible ganglia, distant metastasis, and invasion of the celiac plexus were predictors of less effective response in EUS-CPN for pancreatic cancer-related pain. For these patients, efficacy warrants attention.

gastroenterology & hepatology
Effect of endoscopic ultrasound guided celiac plexus block on the palliation of pain in chronic pancreatitis (EPOCH Trial): study protocol for a randomized multicenter sham-controlled trial {1}

C. Mel Wilcox,Ji Young Bang,James Buxbaum,Timothy B. Gardner,Robert Hawes,Prashant Kedia,Samuel H. Mardini,Thiruvengadam Muniraj,Udayakumar Navaneethan,Veeral M. Oza,Paul Tarnasky,Shyam Thakkar,Irving Waxman,Shyam Varadarajulu,on behalf of the US Pancreatic Disease Study Group,Akwi Asombang,Chloe Bennett,Yan Bi,Wojciech Blogowski,Wei-Shen Chin,Darwin Conwell,Gregory A. Coté,Pramod Garg,Nalini Guda,Yasmin G. Hernandez-Barco,Emily Jonica,Thomas Kowalski,Vivek Kumbhari,Linda Lee,Jorge Machicado,Desiree Morgan,Veeral Oza,Swati Pawa,Rajesh Puri,Amit Rastogi,D. Nageshwar Reddy,Monica Saumoy,Mandeep Sawhney,Santhi Swaroop Vege,Rupjyoti Talukdar,Felix Tellez-Avila,Nikhil Thiruvengadam,Elaina Vivian,Field F. Willingham

DOI: https://doi.org/10.1186/s13063-024-08478-y

IF: 2.728

2024-10-16

Trials

Abstract:Celiac plexus block has been commonly utilized for the treatment of chronic pancreatitis-associated abdominal pain. Prospective studies suggest efficacy in 30 to 50% of patients, although no randomized sham-controlled trials have been performed. The objective of this study is to assess the effect of endoscopic ultrasound (EUS)-guided celiac plexus block on abdominal pain in patients with documented chronic pancreatitis.

medicine, research & experimental
Improving Palliation in Pancreatic Cancer: Intraoperative Celiac Plexus Block for Pain Relief

KENNETH W. SHARP,EMILY J. STEVENS

DOI: https://doi.org/10.1097/00007611-199104000-00014

1991-04-01

Southern Medical Journal

Abstract:Most patients with pancreatic carcinoma are not curable. Surgical palliation of obstructive jaundice and gastric outlet obstruction leaves many patients with severe pain from pancreatic carcinoma. Anesthesiologists have drawn increasing attention to the successful use of postoperative percutaneous celiac plexus block for the treatment of pancreatic pain. Ironically, little attention has been paid to celiac plexus block during laparotomy. We reviewed the cases of 12 patients with pancreatic carcinoma and severe abdominal pain who were treated surgically. All patients had operative celiac plexus block with absolute alcohol at the time of exploratory laparotomy for biliary bypass, gastroenterostomy, or tumor biopsy. Complete postoperative pain relief was obtained in 10 of the 12 patients; two had only partial relief. No operative complications were related to celiac plexus block; one patient died postoperatively of pneumonia. Average postoperative hospital stay was 13 days and average postoperative survival was 3 1/2 months. Most patients had excellent pain relief for at least 2 months or until death. Because most patients treated surgically for pancreatic carcinoma are receiving only palliation with biliary bypass or gastroenterostomy, surgeons should pay increased attention to pain relief. Operative celiac plexus block is easy, safe, and highly effective in relieving the agonizing pain of pancreatic carcinoma.

medicine, general & internal
Multidisciplinary Treatment with Chemotherapy, Targeted Drug, and High-Intensity Focused Ultrasound in Advanced Pancreatic Carcinoma

Ying Yuan,Hong Shen,Xiao-Ye Hu,Fei-Ying Gu,Mo-Dan Li,Xian Zhong

DOI: https://doi.org/10.1007/s12032-011-9892-1

2011-01-01

Medical Oncology

Abstract:This study reports a case of an advanced pancreatic cancer patient with liver metastasis who was treated with a combination of chemotherapy, targeted drugs, and high-intensity focused ultrasound (HIFU). The abdominal pain was successfully relieved after the HIFU therapy. The patient had an 18-month survival with satisfactory quality of life. Large-scale randomized clinical trials are necessary to evaluate the long-term efficacy of HIFU treatment with or without chemotherapy and/or targeted drug therapy for pancreatic carcinoma.
The Role of Endoscopy in the Palliation of Pancreatico-Biliary Cancers: Biliary Drainage, Management of Gastrointestinal Obstruction, and Role in Relief of Oncologic Pain

Giacomo Emanuele Maria Rizzo,Lucio Carrozza,Gabriele Rancatore,Cecilia Binda,Carlo Fabbri,Andrea Anderloni,Ilaria Tarantino

DOI: https://doi.org/10.3390/cancers15225367

2023-11-10

Abstract:Therapeutic endoscopy permits many and various treatments for cancer palliation in patients with bilio-pancreatic cancers, enabling different options, supporting patients during their route to oncologic treatments, and trying to improve their quality of life. Therefore, both endoscopic and endoscopic ultrasound (EUS)-guided techniques are performed in this scenario. We performed a literature review focusing on the role of endoscopy in the palliation of those advanced pancreatic and biliary cancers developing malignant biliary obstruction (MBO), gastric outlet obstruction (GOO), and pain unresponsive to medical therapies. Therefore, we explored and focused on the clinical outcomes of endoscopic procedures in this scenario. In fact, the endoscopic treatment is based on achieving biliary drainage in the case of MBO through endoscopic retrograde cholangiopancreatography (ERCP) or EUS-guided biliary drainage (EUS-BD), while GOO is endoscopically treated through the deployment of an enteral stent or the creation of EUS-guided gastro-entero-anastomosis (EUS-GEA). Furthermore, untreatable chronic abdominal pain is a major issue in patients unresponsive to high doses of painkillers, so EUS-guided celiac plexus neurolysis (CPN) or celiac ganglia neurolysis (CGN) helps to reduce dosage and have better pain control. Therefore, therapeutic endoscopy in the palliative setting is an effective and safe approach for managing most of the clinical manifestations of advanced biliopancreatic tumors.
Effect of Neurolytic Celiac Plexus Block Guided by Computerized Tomography on Pancreatic Cancer Pain

Chun-Lei Zhang,Ting-Jie Zhang,Yu-Na Guo,Li-Qiang Yang,Ming-Wei He,Jing-Zhe Shi,Jia-Xiang Ni

DOI: https://doi.org/10.1007/s10620-007-9905-2

2007-01-01

Digestive Diseases and Sciences

Abstract:The efficacy of neurolytic coeliac plexus block (NCPB) guided by computerized tomography (CT) was compared with pharmacological therapy in the treatment of pain due to pancreatic cancer. The study involved 56 patients who were placed randomly in either a NCPB group and pharmacological therapy group. At day 1, 7, and 14, the visual analogue scale (VAS) pain scores of the NCPB group were significantly lower than those of the pharmacological therapy group ( P < 0.01), with values of 1.3 ± 0.8 versus 4.1 ± 0.9, 1.7 ± 1.1 versus 3.1 ± 1.1, and 2.0 ± 1.1 versus 2.9 ± 0.6, respectively. However, the differences in the improvement of quality of life (QOL) between two groups were not statistically significant. Moreover, the dose of opioid was significantly lower in the patients of group 1 than those of group 2, while the complications related to NCPB were transient. We therefore concludes that CT-guided NCPB with alcohol is an effective and safe modality in the management of intractable pancreatic cancer pain.
A meta-analysis on the efficacy of endoscopic ultrasonography for treatment of pancreatic cancer

Min Xuan,Na Li,Chunyan Wu

DOI: https://doi.org/10.1016/j.clinsp.2024.100348

IF: 2.898

2024-01-01

Clinics

Abstract:OBJECTIVE: This study aimed to systematically evaluate the efficacy and safety of Endoscopic Ultrasonography (EUS) for the treatment of pancreatic cancer.METHODS: The PubMed, Embase, Web of Science, and Google Scholar databases were searched from the inception of the databases to June 2022. RevMan 5.3.0 software was utilized for data analysis. In total, 13 self-descriptive studies, which enrolled 382 patients, were finally included.RESULTS: It was revealed that EUS for the treatment of pancreatic cancer exhibited a lower incidence of adverse reactions (Relative Risk Ration [RR = 0.23], 95 % Confidence interval [95 % CI 0.23-0.23]), a higher success rate (RR = 0.90, 95 % CI 0.90-0.90), and a low failure rate (RR = 0.06, 95 % CI 0.06-0.06). Moreover, EUS-guided Celiac Plexus Neurolysis (EUS-CPN) not only significantly relieved pancreatic cancer patients' pain (RR = 0.83, 95 % CI 0.83-0.83), but also significantly eliminated pain in some patients (RR = 0.09, 95 % CI 0.09-0.09). The effects of EUS on pancreatic cancer treatment were satisfactory, and few adverse reactions were found.CONCLUSION: Owing to the restricted sample size in this meta-analysis, primarily consisting of descriptive studies, it was imperative to conduct more rigorously designed, multi-center, long-term follow-up, larger sample, and Randomized Controlled Trials (RCTs) to validate the findings.

medicine, general & internal
The use of different methods of celiac plexus neurolysis in the treatment of pain syndrome associated with pancreatic cancer

Dmytro M. Romanukha,Andrii M. Strokan,Vadym V. Biloshytsky

DOI: https://doi.org/10.25305/unj.257987

2022-09-29

Ukrainian Neurosurgical Journal

Abstract:Черевне сплетення є визнаною мішенню для інтервенційних методик лікування болю, що виникає внаслідок неоперабельного злоякісного новоутворення підшлункової залози або інших органів, розташованих у верхній половині черевної порожнини. Представлено клінічний випадок пацієнтки, 66 років, з раком підшлункової залози, якій для зменшення больового синдрому здійснено декілька спроб застосувати методики нейролізису сонячного сплетення. У зв’язку з великим розміром пухлини та її проростанням у навколишні органи провести симпатолізис під час біопсії за допомогою ендоскопічної ультрасонографії було неможливо. Спроба нейролізису переднім трансабдомінальним доступом під ультразвуковою навігацією не дала бажаного результату. Задній крізьшкірно-паравертебральний підхід під комп’ютерно-томографічним контролем сприяв значному полегшенню стану пацієнтки. Проведено порівняння різних методик нейролізису сонячного сплетення, їхніх переваг та недоліків використання в закладах охорони здоров’я України. The celiac plexus is a recognized target for interventions to provide pain relief to patients with pain resulting from inoperable malignancies of the pancreas or other organs in the upper abdomen.The clinical case of a 66-year-old female patient with pancreatic cancer who underwent several different techniques of celiac plexus neurolysis to reduce pain is presented. Due to the large size of the tumor and its extension into adjacent organs, it was not possible to perform sympatholysis during the biopsy using endoscopic ultrasonography. An attempt of neurolysis through an anterior transabdominal US-guided approach did not bring the desired result. Posterior percutaneous paravertebral CT-guided approach provided a significant relief of the patient's condition.Comparisons of different methods of the celiac plexus neurolysis and their advantages and disadvantages of use in health care institutions of Ukraine are given.If it is impossible to perform neurolysis with the help of endosonography, anterior transabdominal US-guided approach, or if there are difficulties in performing them, we recommend performing neurolysis by posterior percutaneous-paravertebral CT-guided approach.
Neurolytic Celiac Plexus Block in Cancer Pain Management

CHEN Yi,YAN Zhiping,WANG Jianhua,WANG Xiaolin,LUO Jianjun,ZHU Liang,ZHOU Bo,LI Shuo

DOI: https://doi.org/10.3969/j.issn.1008-6358.2007.06.065

2007-01-01

Abstract:Objective:To evaluate the safety and efficacy of neurolytic celiac plexus bloek(NCBP)in controlling pain due to upper abdominal malignancies.Methods:11 patients with advanced malignancies accepted NCBP.All procedures were performed via pre-crus of diaphragm approach under CT guidance.Results:The technical success was 100% in 11 cases.1 week after the procedure,CR(complete relief),PR(partial relief),and MR(moderate relief)were achieved in 7,3 and 1 patients respec tively,producing the effective rate of 90.9%.2 months after the procedure.CR,PR,and MR were achieved in 5,3 and 3 pa tients respectively,producing the effective rate of 72.7%.Postural hypotension occurred in 3 patients,and diarrhea occurred in 3 patients.Conclusion:NCBP is a safe and effective treatment in controlling pain due to upper abdominal malignancies.
Role of Therapeutic Endoscopic Ultrasound in Management of Pancreatic Cancer: An Endoscopic Oncologist Perspective

Dushyant Singh Dahiya,Saurabh Chandan,Hassam Ali,Bhanu Siva Mohan Pinnam,Manesh Kumar Gangwani,Hashem Al Bunni,Andrew Canakis,Harishankar Gopakumar,Ishaan Vohra,Jay Bapaye,Mohammad Al-Haddad,Neil R Sharma

DOI: https://doi.org/10.3390/cancers15123235

2023-06-18

Abstract:Pancreatic cancer is a highly lethal disease with an aggressive clinical course. Patients with pancreatic cancer are usually asymptomatic until significant progression of their disease. Additionally, there are no effective screening guidelines for pancreatic cancer in the general population. This leads to a delay in diagnosis and treatment, resulting in poor clinical outcomes and low survival rates. Endoscopic Ultrasound (EUS) is an indispensable tool for the diagnosis and staging of pancreatic cancer. In the modern era, with exponential advancements in technology and device innovation, EUS is also being increasingly used in a variety of therapeutic interventions. In the context of pancreatic cancer where therapies are limited due to the advanced stage of the disease at diagnosis, EUS-guided interventions offer new and innovative options. Moreover, due to their minimally invasive nature and ability to provide real-time images for tumor localization and therapy, they are associated with fewer complication rates compared to conventional open and laparoscopic approaches. In this article, we detail the most current and important therapeutic applications of EUS for pancreatic cancer, namely EUS-guided Fine Needle Injections, EUS-guided Radiotherapy, and EUS-guided Ablations. Furthermore, we also discuss the feasibility and safety profile of each intervention in patients with pancreatic cancer to provide gastrointestinal medical oncologists, radiation and surgical oncologists, and therapeutic endoscopists with valuable information to facilitate patient discussions and aid in the complex decision-making process.
Endoscopic Ultrasound-Guided Ablation of Premalignant Pancreatic Cysts and Pancreatic Cancer

Alejandra Vargas,Priyata Dutta,Eileen S. Carpenter,Jorge D. Machicado

DOI: https://doi.org/10.3390/diagnostics14050564

IF: 3.6

2024-03-07

Diagnostics

Abstract:Pancreatic cancer is on the rise and expected to become the second leading cause of cancer-related death by 2030. Up to a one-fifth of pancreatic cancers may arise from mucinous pancreatic cysts, which are frequently present in the general population. Currently, surgical resection is the only curative approach for pancreatic cancer and its cystic precursors. However, only a dismal proportion of patients are eligible for surgery. Therefore, novel treatment approaches to treat pancreatic cancer and precancerous pancreatic cysts are needed. Endoscopic ultrasound (EUS)-guided ablation is an emerging minimally invasive method to treat pancreatic cancer and premalignant pancreatic cysts. Different ablative modalities have been used including alcohol, chemotherapy agents, and radiofrequency ablation. Cumulative data over the past two decades have shown that endoscopic ablation of mucinous pancreatic cysts can lead to cyst resolution in a significant proportion of the treated cysts. Furthermore, novel data are emerging about the ability to endoscopically ablate early and locally advanced pancreatic cancer. In this review, we aim to summarize the available data on the efficacy and safety of the different EUS-ablation modalities for the management of premalignant pancreatic cysts and pancreatic cancer.

medicine, general & internal
Endoscopy-guided ablation of pancreatic lesions: Technical possibilities and clinical outlook

Marianna Signoretti,Roberto Valente,Alessandro Repici,Gianfranco Delle Fave,Gabriele Capurso,Silvia Carrara

DOI: https://doi.org/10.4253/wjge.v9.i2.41

2017-01-01

World Journal of Gastrointestinal Endoscopy

Abstract:Endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP)-guided ablation procedures are emerging as a minimally invasive therapeutic alternative to radiological and surgical treatments for locally advanced pancreatic cancer (LAPC), pancreatic neuroendocrine tumours (PNETs), and pancreatic cystic lesions (PCLs). The advantages of treatment under endoscopic control are the real-time imaging guidance and the possibility to reach a deep target like the pancreas. Currently, radiofrequency probes specifically designed for ERCP or EUS ablation are available as well as hybrid cryotherm probe combining radiofrequency with cryotechnology. To date, many reports and case series have confirmed the safety and feasibility of that kind of ablation technique in the pancreatic setting. Moreover, EUS-guided fine-needle injection is emerging as a method to deliver ablative and anti-tumoral agents inside the tumuor. Ethanol injection has been proposed mostly for the treatment of PCLs and for symptomatic functioning PNETs, and the use of gemcitabine and paclitaxel is also interesting in this setting. EUS-guided injection of chemical or biological agents including mixed lymphocyte culture, oncolytic viruses, and immature dendritic cells has been investigated for the treatment of LAPC. Data on the long-term efficacy of these approaches, and large prospective randomized studies are needed to confirm the real clinical benefits of these techniques for the management of pancreatic lesions.

Endoscopic Ultrasound–Guided Celiac Plexus Neurolysis for Pain Management in Patients with Pancreatic Carcinoma Reasons to Fight a Losing Battle

EUS-CGN Versus EUS-CPN in Pancreatic Cancer

A Prospective Study of Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis for Pain Management in Patients with Pancreatic Carcinoma

How to Improve the Efficacy of Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis in Pain Management in Patients with Pancreatic Cancer: Analysis in A Single Center

Therapeutic role of endoscopic ultrasound in pancreaticobiliary disease: A comprehensive review.

Management of Primary Squamous Cell Carcinoma of the Pancreas: A Case Report.

Which is the Best Surgical Approach for the Pancreatic Cancer? A Classification of Pancreatic Cancer to Guide Operative Decisions is Needed

Endoscopic ultrasound-guided neurolysis in advanced pancreatic cancer: current status

Practice guidelines for endoscopic ultrasound-guided celiac plexus neurolysis

Predictors of pain response after endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain caused by pancreatic malignancy

Effect of endoscopic ultrasound guided celiac plexus block on the palliation of pain in chronic pancreatitis (EPOCH Trial): study protocol for a randomized multicenter sham-controlled trial {1}

Improving Palliation in Pancreatic Cancer: Intraoperative Celiac Plexus Block for Pain Relief

Multidisciplinary Treatment with Chemotherapy, Targeted Drug, and High-Intensity Focused Ultrasound in Advanced Pancreatic Carcinoma

The Role of Endoscopy in the Palliation of Pancreatico-Biliary Cancers: Biliary Drainage, Management of Gastrointestinal Obstruction, and Role in Relief of Oncologic Pain

Effect of Neurolytic Celiac Plexus Block Guided by Computerized Tomography on Pancreatic Cancer Pain

A meta-analysis on the efficacy of endoscopic ultrasonography for treatment of pancreatic cancer

The use of different methods of celiac plexus neurolysis in the treatment of pain syndrome associated with pancreatic cancer

Neurolytic Celiac Plexus Block in Cancer Pain Management

Role of Therapeutic Endoscopic Ultrasound in Management of Pancreatic Cancer: An Endoscopic Oncologist Perspective

Endoscopic Ultrasound-Guided Ablation of Premalignant Pancreatic Cysts and Pancreatic Cancer

Endoscopy-guided ablation of pancreatic lesions: Technical possibilities and clinical outlook